Chiral and achiral macrocyclic bis-diketal diamines, analogs of bicyclam AMD 3100, were synthesized in three steps from the previously obtained 14-membered ring diketal dilactams. Their monoreduction with lithium aluminium hydride gave the corresponding diketal aminolactams. Coupling these with dibromo-pxylene led to xylyl dimer compounds. A second reduction step yielded the expected bis-diketal diamines in the methyl and unsubstituted series. Biological tests on the unreduced and reduced dimers showed both weak anti-HIV and anti-proliferative activities for the bis-diphenyl diketal aminolactam 13b, with a mode of action probably different from that of AMD 3100.
Introduction
Macrocyclic saturated polyamines have generated continuous interest because of their physicochemical and biological properties [1] . Among these derivatives, bicyclams form a new class of compounds that exhibit anti-viral [1b, 2-7] and anti-tumoral [7] [8] [9] activities as antagonists of the chemokine co-receptor CXCR4 of the cell membrane [3] [4] [5] [6] [7] [8] [9] . As anti-HIV-1 agents, they interfere at the virus-cell fusion step in blocking the interaction between CXCR4 and the glycoproteins gp 120 of the viral envelope, i.e. the entry of the virus into the host cell, and thereby its replication [3] [4] [5] [6] [7] . As anti-tumoral agents, they block the binding of CXCR4 with its natural ligand, the chemokine C-X-C, SDF-1α (stromal cell-derived factor), and hence inhibit growth, migration and proliferation of cancerous cells [7] [8] [9] . One of these compounds, the xylyl bicyclam AMD 3100, several synthesis of which have been reported [2b, 3c,10] , has so far proved to be the most specific CXCR4 antagonist with a nanomolar binding affinity [2a, 3a, 4c, 5-7] . However, this molecule presents poor oral bioavailability due to its highly polar nature [5] [6] , and possible cardiac side effects disclosed after Phase II trials [6] . In this light, novel chemical analogs of this bioactive agent were likely to be of interest. In continuation of our work on the synthesis, conformational analysis and binding properties of new macrocyclic 14-membered ring diketal dilactams [11] , and diketal diamines [12] , we report the synthesis of substituted bis-dioxygenated analogs of bicyclam AMD 3100 ( 
Chemistry

Synthesis
Bis-diketal diamines were targeted by a coupling reaction of diketal aminolactams ( Fig. 1) , previously obtained as minor products in the synthesis of diketal diamines by reduction of the corresponding diketal dilactams [12] .
Synthesis of diketal aminolactams
The study was conducted on the two major isomers b (trans-OMe) and c (cis-OMe) [13] of the three already developed series of diketal dilactams (1: R 1 = Ph, R 2 = H; 2: R 1 = H, R 2 = Me; 3: R 1 = R 2 = H), using lithium aluminium hydride (10 equiv.) as reducing agent [12] ,. However, some modifications were made to the previously described reaction conditions to invert the ratio of singly reduced compounds 4-6 to doubly reduced compounds 7-9 (Fig. 2 , Table 1 ). As previously, small amounts of NEt 3 were added to minimize the effect of an elimination side reaction leading to unsaturated ketal aminolactams 10-12 [12] . e Isolated yield by column chromatography; at the end of the process, unidentified polar compounds were invariably isolated in 7-22% yield, which increased with the reaction time.
Comparison of entries 1 and 2 (Table 1) , which recall two earlier experiments carried out from phenyl diketal dilactam 1c [12a] , showed that a lower substrate concentration favoured the formation of diketal aminolactam 4c, the yield of which could be optimized in the conditions of entry 3. Entry 4 reports the optimal formation conditions of both diketal aminolactam 4b and diketal diamine 7b, the reaction always leading mainly to the mono-reduced compound independently of the concentration [12b] . In the methyl series, a better yield of aminolactam 5b was obtained in the conditions of entry 6 (c = 8 × 10 −3 M) compared with the previously reported conditions of entry 5 [12b] . In contrast, the formation of 5c was only perceptible (yield 12%, conversion rate 60%) on decreasing the excess of LAH (6 equiv.) and the reaction time (9 h) (entry 9 compared with entries 7 and 8). In the unsubstituted series the best formation conditions of diketal aminolactams 6b and 6c were found at concentrations 5 × 10 −3 M and 3 × 10 −3 M respectively, using 10 equiv. of LAH (entries 10 and 11). As previously reported [12] , in all the series the reduction occurred with moderate total yields (43-53% for the selected entries) that were difficult to improve. These results may be explained by the presence of polar compounds (Table 1) probably resulting from complexation between the diketal diamines generated and the Li + cation, which could therefore no longer catalyse the reaction [14].
Synthesis of bis-diketal aminolactams
The coupling step between diketal aminolactams 4-6 and the α,α′-dibromo-p-xylene was studied from the substrates obtained in appreciable yields, i.e. from 4b,c, 5b, 6b,c. The reactions were performed with minor variations of literature procedures [2b,3c,10], using K 2 CO 3 as basic agent [2b,3c] . They led to the expected bis-diketal aminolactams 13-15, obtained in moderate to good yields (37-72%), and accompanied in both substituted series by small amounts (6-19%) of bromo ketal aminolactams 16-17, which correspond to single coupling products (Scheme 1).
Scheme 1. Reagents and conditions: α,α′-dibromo-p-xylene (0.5-0.6 equiv.), K 2 CO 3 (1.0-1.2 equiv.), CH 3 CN (c substrate = 50 × 10 −3 M), ∆, 8-10 h.
Synthesis of bis-diketal diamines
Due to the moderate yields of 13c and 15b, the reduction of bis-diketal aminolactams was studied on only 13b, 14b and 15c, i.e. on the isomer of each series obtained with the best yield. The reactions were repeated with LAH (10 equiv.) in THF and in the presence of NEt 3 (0.02 equiv./LAH). An inverse addition order of the reactants, namely the addition of a commercial THF hydride solution to the substrate solution, was adopted due to the small amounts of starting materials available.
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In the phenyl series, the reduction performed at different substrate concentrations and reaction times led to either an incomplete reaction giving rise to a mixture of singly and doubly reduced bis-macrocycles difficult to separate (c substrate = 30 × 10 −3 M, 10 h and 40 × 10 −3 M, 9 h), or a major cleavage reaction regenerating diphenyl diketal diamine 7b (c substrate = 50 and 60 × 10 −3 M, 8 h). In contrast, in the methyl and unsaturated series, diketal diamines 18b and 19c were obtained with 26% and 22% yields respectively (conversion rate 100%) with the following substrate concentrations and reaction times: 18b, c substrate = 100 × 10 −3 M, 9 h; 19c, c substrate = 60 × 10 −3 M, 6 h (Scheme 2). In both cases, the reduction was also partially accompanied by a benzyl cleavage giving rise to the corresponding diketal diamines 8b and 9c, in low yield (9%) compared with the phenyl series.
Scheme 2. Reagents and conditions: LAH (10 equiv.), NEt 3 (0.2 equiv.), THF (c substrate = 60-100 × 10 −3 M), ∆, 6-9 h.
In summary, the access to bis-diketal diamines succeeded in the methyl and unsubstituted series but failed in the phenyl series. The difficulties observed in the reduction of the bis-phenyl aminolactam 13b, in which the 3,3′-Ph, and 7,7′-OMe groups are in a trans position, are probably due to the hindrance of the two faces of the molecule at the level of the 5,5′-CO carbonyl groups, as previously reported in the reduction of trans-OMe phenyl diketal dilactam 1b [12b] . In the two successful series, the reduction took place again with moderate total yields (30-35%) which were difficult to improve as in the formation of compounds 4-9 above.
Characterization
The structure and stereochemistry of all the derivatives 4-19 were established from IR, MS, 1D NMR [ 1 H, 13 C (J MOD)] and 2D NMR [COSY 1H-1H, HSQC (heteronuclear single quantum correlation) and sometimes HMBC (heteronuclear multiple bond correlation)] spectroscopic data, which allowed identification of all the hydrogen and carbon atoms. The characteristics of the monomer compounds 4-12 have already been reported [12b] . Briefly, (i) in the 1 H and 13 C NMR spectra, diamines 7c, 8c, 9b,c, which all possess a symmetry element (C 2 for 7c, 8c, 9c, center for 9b), show only one signal for each pair of identical groups of the macrocycle, whereas diamines 7b and 8b exhibit double signals due to the asymmetry of the two ring chains, and (ii) the reduced carbonyl of trans-OMe aminolactams 4b and 5b correspond to the 12-CO carbonyl of chain 2 in which the 14-OMe group and the 3,10-R substituents are in a cis position [12b]. The 1 H and 13 C NMR spectra of the dimer compounds 13-19 are also simplified due to the presence of a C 2 axis perpendicular to the aromatic linker.
Biological assays
Anti-HIV and anti-tumoral tests were performed on the two synthesized bis-diketal diamines 18b, 19c, and on the three bis-diketal aminolactams 13b,c, 15b, not involved in the last reduction step.
Anti-HIV activity evaluation
Since the anti-HIV activity of AMD 3100 appears to be confined to the T-lymphotropic (X4) HIV strains, i.e. those strains that use the CXCR4 receptor to enter their target cells [7b] , the effects of the above chemical entities were studied in vitro with two T cell lines, MT-4 and CEM-SS, infected by X4 viral isolates. The activity of a given compound on the replication of HIV-1 was measured by quantification of (i) the inhibition of virus-induced cytopathogenicity in infected MT-4 cells, and (ii) the reverse transcriptase (RT) activity associated with virus particles released from infected CEM-SS cells.
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The 50% cytotoxic concentration (CC 50 ) was evaluated in parallel to the 50% inhibitory concentration (IC 50 ) ( Table 2 ). Among the tested compounds, only the bis-diphenyl diketal aminolactam 13b showed an inhibitory activity in regard to HIV-1 infection in CEM-SS cells, but with lower values than AMD 3100. [15] The in vitro anti-proliferative activities of compounds 13b,c, 15b, 18b and 19c were evaluated in triplicate towards ten human cell lines [buccal carcinoma (KB), glioblastoma (SF268), myeloid leukaemia (HL60), mammary carcinoma (MCF7 and MCF7R), colon carcinoma (HCT116), pulmonary carcinoma (A549), prostate adenocarcinoma (PC3), ovary adenocarcinoma (OV3) and hepatocarcinoma (HepG2)] using the classic colorimetric MTS test (Table 3) . Taxotere was used as a positive control at a drug concentration of 2.5 × 10 −10 M. The percentage of cell proliferation inhibition was defined as absorbance in experimental wells compared with absorbance in control wells, after subtraction of the blank values. Under the conditions used (10 −5 M final concentration of tested compounds), the bis-diphenyl diketal aminolactam 13b showed a mild cytotoxic activity of about 50% towards five cell lines (KB, HL60, MCF7, HCT116 and PC3), i.e. a cytotoxicity corresponding approximately to an IC 50 of ≈10 µM. c Data from Ref. [15] .Taxotere was used as a positive control at a drug concentration of 2.5 × 10 −10 M.
Anti-tumoral activity evaluation
Discussion
Biological tests, performed on the synthesized bis-macrocyclic compounds 13b,c, 15b, 18b, 19c gave an encouraging result for one analog compared with the others: bis-phenyl diketal aminolactam 13b showed both a weak anti-HIV-1 activity and some anti-proliferative effects. The interaction of AMD 3100 with the receptor CXCR4 has been described as probably due to binding of two antiperiplanar NH amine functions of the two cyclam moieties with the free carboxylic acid groups of Asp171 and Asp262 located on respectively transmembrane TM-IV and TM-VI of the receptor [4b,6b,7] . This is not possible in 13b since the two NH concerned are involved in amide links. Hence the activity of this compound probably depends on other factors e.g. π-π stacking effects between the 3,3′,10,10′-phenyl substituents of the molecule and aromatic rings of Phe, Tyr and (or) Trp units of the transmembrane.
Conclusion
Variously substituted bis-diketal aminolactams and bis-diketal diamines were prepared in two and three steps respectively from previously and rapidly synthesized macrocyclic diketal dilactams [11a] . The first step, which corresponded to the formation of singly reduced compounds 4-6, was efficient in a 3-14 × 10 −3 M concentration range for five of the six series, but failed from the cis methyl dilactam 2c, the reduction of which led mainly to diamine 8c, irrespective of the concentration. After a coupling stage which gave bis-diketal aminolactams 13-15 in 37-72% yield, the final reduction step allowed the isolation of bis-diketal diamines 18b (R = Me) and 19c (R = H), while a partial reaction or a major benzyl cleavage accompanied the reduction of the phenyl product 13b. Biological assays made on the unreduced and reduced dimer macrocycles showed that the bis-diphenyl diketal aminolactam 13b was the most promising compound, with both weak anti-HIV and antiproliferative activities. These results lead to consider a mode of action different from that of AMD 3100, and indicate the probable importance of phenyl groups susceptible to induce π-π stacking effects with aromatic units of the CXCR4 receptor. The development and biological evaluation of new analogs incorporating phenyl substituents would enable us to test this hypothesis.
6. Experimental 6.1. Chemistry 6.1.1. General remarks Solvents were obtained dried as follows: tetrahydrofuran (THF) was distilled from benzophenone ketyl, CH 2 Cl 2 and CH 3 CN were refluxed over and distilled from CaH 2 , CH 3 OH was distilled from magnesium. The organic layers were dried with Mg 2 SO 4 . Reactions were monitored by thin layer chromatography (TLC) on aluminium plates precoated with silica gel (Merck 60 F 254 ) and spots visualized by UV light or by spraying with a ceric sulphate and ammonium molybdate acid solution. Flash chromatography was carried out with silica gel (Merck 0.040-0.063 mm). Optical rotations were measured at the sodium D line (589 nm) using a 1 dm quartz cell with a JASCO DIP-370 apparatus. IR spectra were scanned with a Perkin-Elmer 881 spectrophotometer (ν max in cm −1 ). 1D ( 1 H and 13 C-J MOD) and 2D (COSY 1 H-1 H, HSQC 1 H-13 C) NMR spectra were recorded with a Bruker Avance 400 spectrometer equipped with a 1 H/ 13 C probe ( 1 H: 400 MHz; 13 C: 100 MHz), and 2D HMBC 1 H-13 C NMR spectra with an Avance 500 apparatus long dist 7.7 Hz ( 1 H: 500 MHz; 13 C: 125 MHz). Chemical shifts δ were noted in parts per million (ppm) and splitting patterns designated as follows: singlet (s), doublet (d) , triplet (t), quartet (q), doubled doublet (dd), doublet of doublet of doublet (ddd), doubled triplet (dt), multiplet (m), broad signal (br. s). The solvent (CDCl 3 ) was taken as internal reference [δ = 7.27 ppm for 1 H NMR and 77.1 ppm (central line) for 13 C NMR]. Proton and carbon atoms were assigned according to the numbering indicated in Fig. 2 and Scheme 1. Mass spectra were recorded with either an HP 5989B (CI) or a micro Q-TOF Waters (ESI) apparatus.
Diketal aminolactams: general procedure
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To a suspension of LiAlH 4 (10 equiv.) in dry THF (0.5 mL for 1 mmol of LAH) was added NEt 3 (0.01-0.04 equiv./LAH), and dropwise a solution of diketal dilactam (1 equiv.) in dry THF (c substrate = 3-14 × 10 −3 M). The reaction mixture was heated at reflux while stirring for 9-18 h. Excess hydride was destroyed by adding H 2 O (10 equiv./LAH). The precipitates were filtered and washed with THF and CH 2 Cl 2 . The organic layer was dried with MgSO 4 and evaporated in vacuo. Purification by flash chromatography (silicagel, Et 2 O/MeOH) yielded diketal aminolactams and diketal diamines.
(3R,7R,10R,14S)-Diphenyl diketal aminolactam (4b), (3R,7R,10R,14S)-diphenyl diketal diamine (7b)
The preparation of these compounds was described previously [12b]. (4c), (3R,7S,10R,14S 
(3R,7S,10R,14S)-Diphenyl diketal aminolactam
(3S,7S,10S,14R)-Dimethyl diketal aminolactam (5b), (3S,7S,10S,14R)-dimethyl diketal diamine (8b), and (3S,10S,14R)-dimethyl unsaturated ketal aminolactam (11)
These compounds were prepared from methyl diketal dilactam 2b (63. (15.0 mg, 49.3 µmol, 28%) , diketal diamine 8b (6.1 mg, 21.1 µmol, 12%) and unsaturated ketal aminolactam 11 (0.9 mg, 3.5 µmol, 2%) with 88% conversion rate. Data of 5b, 8b, and 11 were given previously [12b].
(3S,7R,10S,14R)-Dimethyl diketal aminolactam (5c), (3S,7R,10S,14R)-dimethyl diketal diamine (8c) and (3S,10S,14R)-dimethyl unsaturated ketal aminolactam (11)
These compounds were prepared from methyl diketal dilactam 2c (63.7 mg, 0.20 mmol), LiAlH 4 (45.5 mg, 1.2 mmol, 6 equiv.), NEt 3 (1 M solution in THF, 12 µL, 12 µmol, 0.01 equiv./LAH), and THF (50 mL, c substrat = 4.0 × 10 −3 M) according to the general procedure (reaction time 9 h). Excess hydride was destroyed by adding H 2 O (216 µL, 12 mmol). Chromatography (Et 2 O/MeOH, gradient 100:0-0:100) afforded diketal aminolactam 5c (4.4 mg, 14.4 µmol, 12%), diketal diamine 8c (7.7 mg, 26.4 µmol, 22%) and unsaturated ketal aminolactam 11 (0.3 mg, 1.2 µmol, 1%) with 60% conversion rate. Data of 5c, 8c, and 11 were given previously [12b].
(7S*,14R*)-Diketal aminolactam (6b), (7S*,14R*)-diketal diamine (9b), and 14R*-unsaturated ketal aminolactam (12)
These compounds were prepared from diketal dilactam 3b (72.6 mg, 0.25 mmol), LiAlH 4 (95 mg, 2.5 mmol, 10 equiv.), NEt 3 (1 M solution in THF, 50 µL, 50 µmol, 0.02 equiv./LAH), and THF (50 mL, 
Bis-diketal aminolactams: general procedure
A suspension of diketal aminolactam, α,α′-dibromo-p-xylene (0.5-0.6 equiv.) and K 2 CO 3 (1.0-1.2 equiv.) in dry CH 3 CN (c substrate = 50 × 10 −3 M) was heated at reflux while stirring for 8-9 h. After evaporation of the solvent, the residue was dissolved in CH 2 Cl 2 . The precipitate was filtered and washed with CH 2 Cl 2 . The organic layer was dried with Mg 2 SO 4 and evaporated in vacuo. Purification by flash chromatography (silica gel, Et 2 O/MeOH) yielded bis-diketal aminolactams and small amounts of bromo diketal aminolactams.
Bis-(3R,7R,10R,14S)-diphenyl diketal aminolactam (13b) and (3R,7R,10R,14S)-bromoxylyl diphenyl diketal aminolactam (16b)
These compounds were prepared from diphenyl diketal aminolactam 4b (25.7 mg, 60.0 µmol), α,α′-dibromo-p-xylene (7.9 mg, 30.0 µmol, 0.5 equiv.), K 2 CO 3 (8.3 mg, 60.0 µmol, 1.0 equiv.), and CH 3 CN (1.2 mL, c substrate = 50 × 10 −3 M) according to the general procedure (reaction time 8 h). Chromatography (Et 2 O/MeOH, gradient: 100:0-50:50) afforded bis-diketal aminolactam 13b (16.0 mg, 16.8 µmol, 61%) and bromoxylyl diphenyl diketal aminolactam 16b (5.4 mg, 8.8 µmol, 16%) = 7.3 Hz), 4.79 (dd, 2H, 3 J = 8.7, 1.5 Hz), 4.84 (t, 2H, 3 J = 5.3 Hz), 5.28 (ddd, 2H, 3 J = 7.9, 3.2, 2.9 Hz), 24H, 7.90 (d, 2H, 2 NH lactam,  3 J = 7.9 Hz). 13 C NMR and HSQC (100 MHz, CDCl 3 ): δ C 31.1 (2C-13), 40.0 (2C-6), 44.7 (2C-12), 52.0 (2 OCH 3 ), 52.3 (2C-3), 53.4 (2CH 3 ), 53.5 (2C-15), 63.4 (2C-10), 66.4 (2C-9) , 70.5 (2C-2), 100.1 (2C-7) 
Bis-(3R,7S,10R,14S)-diphenyl diketal aminolactam (13c) and (3R,7S,10R,14S)-bromoxylyl diphenyl diketal aminolactam (16c)
These compounds were prepared from diphenyl diketal aminolactam 4c ( 1 H NMR and COSY 1 H13), 33.7 (CH 2 Br), 41.2 (C-6), 45.3 (C-12), 52.5 (C-3), 52.6 (OCH 3 ), 54.2 (C-15), 53.3 (OCH 3 ), 63.1 (C-10), 67.3 (C-9), 69.8 (C-2), 101.8 (C-7), 102.2 (C-14), 127.0-129.2 (14 Ar-CH), 136.4 (Ar-C), 138.0 (Ar-C), 139.6 (Ar-C), 140.6 (Ar-C), 168.6 (CO The cell cultures of MT-4 and CEM-SS cells were maintained at 37 °C in a 5% CO 2 atmosphere in RPMI 1640 medium supplemented with 10% foetal calf serum (FCS) containing penicillin, streptomycin and glutamine. MT-4 cells were infected with HIV-1 IIIB isolate at 5 TCID 50 (Tissue Culture Infective Dose) and CEM-SS cells with HIV-1 LAI isolate at 20 TCID 50 . After 30 min of adsorption, the infected cells were washed to remove unadsorbed virus particles and resuspended in RPMI at the final concentration of 10 5 cells/mL, in the presence of various dilutions of the test compounds. After 5 days, virus production was measured as already described [16] . The 50% inhibitory concentration (IC 50 ) was derived from the computer-generated median effect plot of the dose-effect data [17] . The cytotoxicity of the drugs was evaluated in parallel by incubating uninfected cells in the presence of ranging concentrations of anti-viral products. Cell viability was measured by means of a colorimetric reaction based on the capacity of mitochondrial dehydrogenase of living cells to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into formazan, the quantity of which was determined by the optical density at 540 nm [18] . The 50% cytotoxic concentration (CC50) was calculated with the program used for the determination of IC 50 . The CEM-SS cells were obtained from P. Nara through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH.
Anti-tumoral activity
The cell cultures were maintained at 37 °C under 5% CO 2 atmosphere for 72 h, in either RPMI 1640 medium (cell lines: SF268, HL60, MCF7, MCF7R, HCT116, A549, PC3, OV3) or DMEM-Glutamax medium (cell lines: KB, HepG2), supplemented in both cases with 10% foetal calf serum (FCS) containing penicillin, streptomycin, fungizon and glutamine. Cells were plated at a density of 500-800 cells in 200 µL culture medium in each well of 96-well microplates and allowed to adhere for 24 h before treatment with test drugs in DMSO solution (final concentration: 10 −5 M). Cell viability was assayed after 3 h drug exposure with tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium salt, MTS, Promega Corp.] using the Cell
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Titer 96 Aqueous One Solution Cell Proliferation Assay kit (Promega Corp) according to the manufacturer's instructions. Absorbance was measured at 490 nm with a microplate reader.
